Read More Pharma Industry News Eli Lilly to acquire Morphic in $3.2bn deal to expand integrin therapy development In a major strategic move, Eli Lilly and Company (NYSE: LLY) has announced a definitive agreement to acquire… byPallavi MadhirajuJuly 9, 2024